Search
Kamada Ltd
KMDAAdd to Watchlist
7.500USD
-0.020-0.27%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
432.65MMarket Cap
21.41P/E TTM
More Details of Kamada Ltd Company
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Kamada Ltd Info
Ticker SymbolKMDA
Company nameKamada Ltd
IPO dateAug 01, 2005
CEOLondon (Amir)
Number of employees374
Security typeOrdinary Share
Fiscal year-endAug 01
Address2 Holtzman St., Science Park
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7670402
Phone97289406472
Websitehttps://www.kamada.com/
Ticker SymbolKMDA
IPO dateAug 01, 2005
CEOLondon (Amir)
Company Executives of Kamada Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Ms. Pnina Strauss
Ms. Pnina Strauss
Vice President - Inhalation programs & IP
Vice President - Inhalation programs & IP
--
--
Mr. Tuvia Shoham
Mr. Tuvia Shoham
Independent Director
Independent Director
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
DR. Naveh Tov
DR. Naveh Tov
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
FAQs
Who are the top five shareholders of Kamada Ltd?
The top five shareholders of Kamada Ltd are: Mr. Leon Yehuda Recanati
How many institutions hold shares of Kamada Ltd (KMDA)?
As of 2026Q1, 98 institutions hold shares of Kamada Ltd, with a combined market value of approximately 28.17M, accounting for 48.83% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -2157241.00.